Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 9,165,179 $ 7,188,553
Marketable securities 4,086,873 15,861,620
Accounts receivable 0 39,881
Prepaid research and development 219,817 1,117,616
Prepaid expenses and other current assets 739,179 163,452
Total current assets 14,211,048 24,371,122
Equipment and improvements, net 73,372 236,532
Right-of-use asset 222,227 328,643
Total assets 14,506,647 24,936,297
Current liabilities:    
Accounts payable 646,767 1,151,173
Lease obligation, current 150,095 145,836
Accrued expenses and other current liabilities 2,259,955 2,398,436
Insurance premium financing payable 381,784 0
Total current liabilities 3,438,601 3,695,445
Lease obligations, net of current portion 90,124 205,451
Total liabilities 3,528,725 3,900,896
Commitments and contingencies (see Note 14)
Stockholders' equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized at December 31, 2023 and 2022; 0 shares issued and outstanding at December 31, 2023 and 2022 0 0
Common stock, $0.001 par value; 100,000,000 shares authorized; 6,186,280 and 4,224,294 shares issued and outstanding at December 31, 2023 and 2022 6,186 4,224
Additional paid-in capital 77,871,584 68,798,301
Accumulated other comprehensive income 877 104,718
Accumulated deficit (66,900,725) (47,871,842)
Total stockholders' equity 10,977,922 21,035,401
Total liabilities and stockholders' equity $ 14,506,647 $ 24,936,297